Brief: InDex Pharmaceuticals Q4 EBIT SEK -107.9 Million

Flerie AB

21/02/2024 07:00

Feb 21 (Reuters) - InDex Pharmaceuticals Q4 sales SEK 0.
* Q4 adjusted EPS SEK -0.2
* Q4 cash flow from operating activities SEK -47 million
* Q4 net income SEK -105.5 million